Absorption |
Blood-Brain Barrier | BBB- | 0.9829 |
Human Intestinal Absorption | HIA+ | 0.6421 |
Caco-2 Permeability | Caco2- | 0.7130 |
P-glycoprotein Substrate | Substrate | 0.7326 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7661 |
Inhibitor | 0.8870 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8788 |
Distribution |
Subcellular localization | Lysosome | 0.4660 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.9056 |
CYP450 2D6 Substrate | Non-substrate | 0.8164 |
CYP450 3A4 Substrate | Substrate | 0.6034 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7454 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7202 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8809 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6663 |
CYP450 3A4 Inhibitor | Inhibitor | 0.6783 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7751 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9937 |
Non-inhibitor | 0.8319 |
AMES Toxicity | Non AMES toxic | 0.8794 |
Carcinogens | Non-carcinogens | 0.8299 |
Fish Toxicity | High FHMT | 0.9635 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9520 |
Honey Bee Toxicity | Low HBT | 0.5464 |
Biodegradation | Not ready biodegradable | 0.9967 |
Acute Oral Toxicity | IV | 0.4760 |
Carcinogenicity (Three-class) | Non-required | 0.5248 |